CMS Issued Guidance on Biosimilars

  • FLASCO
  • May 3, 2015

 

CMS Issued Guidance on Biosimilars

Please review CMS Coverage of Biosimilars for more information.

See new codes below:

HCPCS Code Short Description Long Description Action Coverage Pricing Effective Date
Q5101 Inj filgrastim g-csf biosim Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram Add D 51 7/1/2015
Q9976 Inj Ferric Pyrophosphate Cit Injection, Ferric Pyrophosphate Citrate Solution, 0.1 mg of iron Add C 51 7/1/2015
Q9977 Compounded Drug NOC Compounded Drug, Not Otherwise Classsified Add D 51 7/1/2015
JF Compounded Drug Compounded Drug Discontinue C 6/30/2015
Q9978 Netupitant Palonosetron oral Netupitant 300 mg and Palonosetron 0.5 mg, oral Add D 51 7/1/2015
S8262 Mandib ortho repos device Mandibular Orthopedic Repositioning Device, Each Discontinue I 0 6/30/2015

 

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO